Published on: 16th April, 2025 The Central Drugs Standard Control Organization (CDSCO) has released a crucial directive dated 11th April, 2025, addressing the unauthorized manufacture and marketing of Fixed Dose Combinations (FDCs) by pharmaceutical manufacturers in India. The notification highlights…
26 February, 2025 The Central Drugs Standard Control Organization (CDSCO) has issued a circular dated 24.02.2025 for all the manufacturers of Category D Fixed Dose Combinations (FDCs). CDSCO has previously provided two separate pathways for the approvals of Category D…
25th February,2025 The pharmaceutical industry operates under strict regulations to ensure the safety, efficacy, and quality of drugs available in the market. One of the critical aspects of drug classification in India is the definition of a "New Drug" under…
Recent Post
- CDSCO Issues Public Notice on Disposal of Long-Pending SUGAM Applications
- India Bans High-Dose Nimesulide: What You Need to Know
- Compounding of Offences under the Drugs and Cosmetics Act, 1940: What Stakeholders Need to Know
- 🚨 CDSCO Directive on Immediate Inspections as per Revised Schedule M – Is Your Facility Ready?
- CDSCO Issues Regulatory Clarification on Combi-Pack Approvals: Key Insights for Injectable Manufacturers
